5-substituted-pyrazine or pyridine glucokinase activators

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 241/26 (2006.01) A61K 31/44 (2006.01) A61K 31/4436 (2006.01) A61K 31/50 (2006.01) A61K 31/501 (2006.01) A61P 3/10 (2006.01) C07D 213/75 (2006.01) C07D 213/76 (2006.01) C07D 213/78 (2006.01) C07D 241/20 (2006.01) C07D 403/04 (2006.01) C07D 403/06 (2006.01) C07D 405/04 (2006.01) C07D 405/06 (2006.01) C07D 409/04 (2006.01) C07D 413/04 (2006.01) C07D 417/06 (2006.01)

Patent

CA 2506441

The present invention provides a compound according to formula (I) where the substituent designations are provided in the specification. Pharmaceutical compositions comprising a compound according to formula (I) are also provided, said compounds being glucokinase activators which are useful in the treatment of type II diabetes.

La présente invention se rapporte à des composés représentés par la formule (I), dont les substituants sont tels que décrits dans l'invention. L'invention a également trait à des compositions pharmaceutiques contenant les composés représentés par la formule (I). Lesdits composés sont des activateurs de la glucokinase, qui sont utiles pour traiter le diabète de type II.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

5-substituted-pyrazine or pyridine glucokinase activators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5-substituted-pyrazine or pyridine glucokinase activators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-substituted-pyrazine or pyridine glucokinase activators will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1598339

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.